PHARMACEUTICAL PRODUCT DEVELOPMENT INC Pre-Tax Income
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Pre-Tax Income of $50.70 million for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2011-09-30 was $50.70M, a 4.61% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2011-06-30 was $66.79M, a 62.56% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2010-09-30 was $53.15M.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2010-06-30 was $41.08M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month |
|---|---|---|---|
| 2011-09-30 | $50.70M 10-Q · filed 2011-11-02 | $117.49M derived: sum of 2 quarters · filed 2011-11-02 | $172.44M 10-Q · filed 2011-11-02 |
| 2011-06-30 | $66.79M 10-Q · filed 2011-08-04 | $121.74M 10-Q · filed 2011-08-04 | |
| 2010-09-30 | $53.15M 10-Q · filed 2011-11-02 | $94.23M derived: sum of 2 quarters · filed 2011-11-02 | $121.15M 10-Q · filed 2011-11-02 |
| 2010-06-30 | $41.08M 10-Q · filed 2011-08-04 | $68.00M 10-Q · filed 2011-08-04 |